AYU ARIFTA PUTRI, - (2022) COVID-19 IN AUTOIMMUNE RHEUMATIC DISEASES: PATIENTS PROFILE AT DR. SOETOMO HOSPITAL IN 2020-2022. Skripsi thesis, UNIVERSITAS AIRLANGGA.
![[img]](https://repository.unair.ac.id/style/images/fileicons/text.png) |
Text (HALAMAN I)
011911133083 HALAMAN I.pdf Download (298kB) |
|
Text (BAB I)
011911133083 BAB I.pdf Download (40kB) |
|
Text (FULL TEXT)
011911133083.pdf Restricted to Registered users only Download (1MB) | Request a copy |
Abstract
Background: Coronavirus Disease 2019 (COVID-19) was declared as a pandemic since it rapidly became worldwide spread. COVID-19 has various manifestations, ranging from asymptomatic to life-threatening conditions. During the pandemic, patients with autoimmune rheumatic diseases (ARD) are individuals who are included in the population at risk. In addition, the use of immunomodulatory and/or immunosuppressive agents are considered to increase the susceptibility to the infection. Studies reported that COVID-19 and ARD have similarities in clinical findings and immune response. The aim of this study is to know the profile of patients with ARD infected with COVID-19 at Dr. Soetomo Hospital in 2020 – 2022. Methods: An observational cross-sectional study using medical records in ARD patients was carried out in the rheumatology outpatient clinic at Dr. Soetomo Hospital, Surabaya. Results: The total population in this study was 200 patients. 49 of 200 (24.5%) had been infected with COVID-19. This study had female predominance (93.9%) and a mean age of 43±14.3 years. The most common primary ARD diagnoses were undifferentiated spondyloarthritis (SpA), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), psoriatic arthritis, accounting for 44.9%, 32.7%, 16.3%, and 4.1% respectively. Methylprednisolone was taken by 65.3% of the sample. Despite the infection, 57.1% of ARD patients chose to continue their ARD medication. 63,2% of ARD patients had asymptomatic-mild COVID-19 conditions and the rest of them had moderate-severe COVID-19 conditions. There were 14 cases (28.6%) that were developing ARD post-covid infection. Conclusion: The proportion of COVID-19 among ARD patients was 24,5%.
| Item Type: | Thesis (Skripsi) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Additional Information: | KKA KK S.FK.D 164 - 23 Ayu c | |||||||||
| Uncontrolled Keywords: | Autoimmune rheumatic disease, COVID-19, Surabaya, proportion, DMARDs, human & health | |||||||||
| Subjects: | R Medicine > RC Internal medicine > RC31-1245 Internal medicine | |||||||||
| Divisions: | 01. Fakultas Kedokteran > S1 Kedokteran | |||||||||
| Creators: |
|
|||||||||
| Contributors: |
|
|||||||||
| Depositing User: | Dewi Puspita | |||||||||
| Date Deposited: | 26 Aug 2026 08:57 | |||||||||
| Last Modified: | 26 Aug 2026 08:57 | |||||||||
| URI: | http://repository.unair.ac.id/id/eprint/145122 | |||||||||
| Sosial Share: | ||||||||||
Actions (login required)
 |
View Item |